Matrix Metalloproteinase Biology
Herausgegeben von Sagi, Irit; Gaffney, Jean
Matrix Metalloproteinase Biology
Herausgegeben von Sagi, Irit; Gaffney, Jean
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Discussing recent advances in the field of matrix metalloproteinase (MMP) research from a multidisciplinary perspective, Matrix Metalloproteinase Biology is a collection of chapters written by leaders in the field of MMPs. The book focuses on the challenges of understanding the mechanisms substrate degradation by MMPs, as well as how these enzymes are able to degrade large, highly ordered substrates such as collagen. All topics addressed are considered in relation to disease progression including roles in cancer metastasis, rheumatoid arthritis and other inflammatory diseases.
The text…mehr
Andere Kunden interessierten sich auch für
- Lorenzo A. PinnaProtein Kinase Ck2237,99 €
- The Septins199,99 €
- Brenda D. SpanglerMethods in Molecular Biology and Protein Chemistry167,99 €
- Advances in Enzymology and Related Areas of Molecular Biology, Volume 77165,99 €
- Novartis Foundation SymposiumMolecular Clocks and Light Signalling214,99 €
- G Protein-Coupled Receptors126,99 €
- Pascal DolléThe Retinoids200,99 €
-
-
-
Discussing recent advances in the field of matrix metalloproteinase (MMP) research from a multidisciplinary perspective, Matrix Metalloproteinase Biology is a collection of chapters written by leaders in the field of MMPs. The book focuses on the challenges of understanding the mechanisms substrate degradation by MMPs, as well as how these enzymes are able to degrade large, highly ordered substrates such as collagen. All topics addressed are considered in relation to disease progression including roles in cancer metastasis, rheumatoid arthritis and other inflammatory diseases.
The text first provides an overview of MMPs, focusing on the history, the development and failures of small molecule inhibitors in clinical trials, and work with TIMPS, the endogenous inhibitors of MMPs. These introductory chapters establish the foundation for later discussion of the recent progress on the design of different types of inhibitors, including novel antibody based therapeutics. The following section emphasizes research using novel methods to further the study of the MMPs. The third and final section focuses on in vivo research, particularly with respect to cancer models, degradation of the extracellular matrix, and MMP involvement in other disease states.
Written and edited by leaders in the field, Matrix Metalloproteinase Biology addresses the rapidly growth in MMP research, and will be an invaluable resource to advanced students and researchers studying cell and molecular biology.
The text first provides an overview of MMPs, focusing on the history, the development and failures of small molecule inhibitors in clinical trials, and work with TIMPS, the endogenous inhibitors of MMPs. These introductory chapters establish the foundation for later discussion of the recent progress on the design of different types of inhibitors, including novel antibody based therapeutics. The following section emphasizes research using novel methods to further the study of the MMPs. The third and final section focuses on in vivo research, particularly with respect to cancer models, degradation of the extracellular matrix, and MMP involvement in other disease states.
Written and edited by leaders in the field, Matrix Metalloproteinase Biology addresses the rapidly growth in MMP research, and will be an invaluable resource to advanced students and researchers studying cell and molecular biology.
Produktdetails
- Produktdetails
- Verlag: Wiley & Sons
- 1. Auflage
- Seitenzahl: 232
- Erscheinungstermin: 3. August 2015
- Englisch
- Abmessung: 261mm x 182mm x 17mm
- Gewicht: 645g
- ISBN-13: 9781118772324
- ISBN-10: 1118772326
- Artikelnr.: 41753774
- Verlag: Wiley & Sons
- 1. Auflage
- Seitenzahl: 232
- Erscheinungstermin: 3. August 2015
- Englisch
- Abmessung: 261mm x 182mm x 17mm
- Gewicht: 645g
- ISBN-13: 9781118772324
- ISBN-10: 1118772326
- Artikelnr.: 41753774
Irit Sagi is Incumbent of the Maurizio Pontecorvo Professorial Chair in the Department of Biological Regulation at the Weizmann Institute of Science, Rehovot, Israel. Jean P. Gaffney completed her postdoctoral work in Dr. Sagi's laboratory at the Weizmann Institute of Science, Rehovot, Israel. She is an Assistant Professor of Chemistry at Baruch College, City University of New York, New York, NY, USA.
List of Contributors ix 1 Matrix Metalloproteinases: From Structure to
Function 1 Maciej J. Stawikowski and Gregg B. Fields 1.1 Introduction 1 1.2
Structures of MMPs 1 1.2.1 General MMP structure and domain organization 1
1.2.2 Catalytic domain 2 1.2.3 Catalytic mechanism 3 1.2.4 Fibronectin type
II-like inserts 3 1.2.5 Linker region 4 1.2.6 Hemopexin-like domain 6 1.2.7
Transmembrane domain and cytoplasmic tail 7 1.3 Overview of MMP substrate
specificity 8 1.3.1 ECM substrates 9 1.3.2 Cell surface substrates 10 1.3.3
Intracellular MMP targets 11 1.4 Selective mechanisms of action 13 1.4.1
Collagenolysis 13 1.4.2 Gelatinolysis 15 Acknowledgments 16 References 16 2
Dynamics and Mechanism of Substrate Recognition by Matrix Metalloproteases
23 Ivan E. Collier and Gregory I. Goldberg 2.1 Introduction 23 2.2
Conformational flexibility of MMPs is inexorably linked to collagen
proteolysis 24 2.3 Dynamics of MMP-2 and MMP-9 interaction with gelatin 26
2.4 Surface diffusion: a common mechanism for substrate interaction adapted
by MMP-2 and MMP-9 26 2.5 Dynamics of MMP interaction with collagen fibrils
28 2.6 Mechanism of interaction of MMP-1, MMP-2, MMP-9, and MMP-14 with
collagen substrate involves surface diffusion 28 2.7 Mechanism of MMP-1
diffusion on native collagen fibrils 30 2.8 Triple helical collagen
cleavage - diffusion coupling 31 2.9 Conclusions 34 References 36 3 Matrix
Metalloproteinases: From Structure to Function 41 Marco Fragai and Claudio
Luchinat 3.1 Introduction 41 3.2 Classification and structural features 42
3.3 Catalytic mechanism 45 3.4 Intra- and inter-domain flexibility 47 3.5
Elastin and collagen degradation 47 References 54 4 Metzincin Modulators 61
Dmitry Minond 4.1 Inhibitors 61 4.1.1 Antibodies: targeting beyond the
active site 61 4.1.2 Peptide-based inhibitors 65 4.1.3 Small molecules:
non-zinc binding exosite inhibitors 68 4.1.4 Protein-based inhibitors 78
Summary and future directions 80 References 81 5 Therapeutics Targeting
Matrix Metalloproteinases 85 Jillian Cathcart, Ashleigh Pulkoski-Gross,
Stanley Zucker, and Jian Cao 5.1 Introduction 85 5.2 Peptidomimetic MMP
inhibitors 86 5.3 Structure-based MMPI drug design 87 5.4 Mechanism-based
MMPI design 89 5.5 Allosteric MMPI design 90 5.6 Macromolecular MMP
inhibitors 91 5.7 Chemically-modified tetracyclines 93 5.8 Alternative
approaches 94 5.9 MMPs as anti-targets 95 5.10 Conclusions 97 References 98
6 Matrix Metalloproteinase Modification of Extracellular Matrix-Mediated
Signaling 103 Howard C. Crawford and Sharon M. Stack 6.1 Introduction 103
6.2 The extracellular matrix as a source for signaling ligands 104 6.3 ECM
and mechanosensory signal transduction 106 6.4 Matrix remodeling and
modification of mechano-sensory signaling 108 6.5 Conclusions and future
directions 109 References 109 7 Meprin and ADAM Metalloproteases: Two Sides
of the Same Coin? 115 Christoph Becker-Pauly and Stefan Rose-John 7.1
Introduction 115 7.2 Meprin metalloproteases 116 7.3 Structure of meprin
alpha and meprin ß 116 7.4 Proteomics for the identification of meprin
substrates 118 7.5 Meprins in health and disease 118 7.6 Proteolytic
back-and-forth of meprins and ADAMs 119 7.7 Collagen fibril formation 119
7.8 Angiogenesis and cancer 120 7.9 Inflammation 121 7.10 ADAM Proteases
121 7.11 The ADAM family of proteases 123 7.12 Orchestration of different
pathways by ADAM17 123 7.13 Regulation of ADAM17 activity 123 7.14 Role of
ADAM17 in vivo 125 7.15 Role of ADAM17 in humans 125 References 126 8
Subtracting Matrix Out of the Equation: New Key Roles of Matrix
Metalloproteinases in Innate Immunity and Disease 131 Antoine Dufour and
Christopher M. Overall 8.1 The tale of a frog's tail 131 8.2 The MMP family
132 8.3 Making the cut as immune regulators 133 8.4 Enter the "omics" era:
genomics, proteomics and degradomics 137 8.5 ECM versus non-ECM MMP
substrates 138 8.6 Moonlighting protein substrates: intracellular proteins
cleaved outside the cell 142 8.7 Intracellular protein substrates cleaved
inside the cell by MMPs 143 8.8 Non-proteolytic roles of MMPs: missed in
the myth? 145 8.9 The fairy tail of a frog has an unexpected ending 149
Acknowledgements 149 References 149 9 MMPs: From Genomics to Degradomics
153 Barbara Grünwald, Pascal Schlage, Achim Krüger, and Ulrich auf dem
Keller 9.1 Introduction 153 9.1.1 Genomics: general aspects 154 9.1.2 The
genomics approach to MMP function in cancer 155 9.1.3 Taking first steps
towards MMP inhibition in cancer therapy 156 9.1.4 Lessons from the failure
of unselective MMP inhibition 157 9.1.5 Limitations of the genomic approach
to MMP function 160 9.1.6 Approaching proteolysis as a system 161 9.2
Degradomics - An Overview 164 9.2.1 Global assessment of MMP expression and
activity 166 9.2.2 Defining MMP active site specificity 168 9.2.3 MMP
substrate degradomics 169 9.2.4 Targeted degradomics 171 9.2.5 Data
integration and repositories 173 9.3 Conclusions 174 Acknowledgments 174
References 174 10 MMPs in Biology and Medicine 183 Di Jia, Roopali Roy, and
Marsha A. Moses 10.1 Introduction 183 10.2 Functional roles of MMPs and
ADAMs 184 10.2.1 ECM remodeling 184 10.2.2 Processing of growth factors and
receptors 185 10.2.3 Modulation of cell migration, invasion, proliferation,
and epithelial to mesenchymal transition (EMT) 186 10.2.4 Regulation of
angiogenesis 187 10.3 MMPs as diagnostic and prognostic biomarkers of
cancer 187 10.3.1 Breast cancer 188 10.3.2 Prostate cancer 189 10.3.3 Lung
cancer 190 10.3.4 Pancreatic cancer 191 10.3.5 Ovarian cancer 192 10.4
MMPs/ADAMs as diagnostic and prognostic biomarkers for non-neoplastic
diseases 192 10.4.1 Cardiovascular diseases 193 10.4.2 Endometriosis 193
10.4.3 Preeclampsia 195 10.4.4 Arthritis 196 10.5 MMPs as biomarkers of
therapeutic efficacy 197 10.6 MMP-specific molecular imaging for
noninvasive disease detection 201 10.7 Conclusions 202 Acknowledgments 203
References 203 Index 215
Function 1 Maciej J. Stawikowski and Gregg B. Fields 1.1 Introduction 1 1.2
Structures of MMPs 1 1.2.1 General MMP structure and domain organization 1
1.2.2 Catalytic domain 2 1.2.3 Catalytic mechanism 3 1.2.4 Fibronectin type
II-like inserts 3 1.2.5 Linker region 4 1.2.6 Hemopexin-like domain 6 1.2.7
Transmembrane domain and cytoplasmic tail 7 1.3 Overview of MMP substrate
specificity 8 1.3.1 ECM substrates 9 1.3.2 Cell surface substrates 10 1.3.3
Intracellular MMP targets 11 1.4 Selective mechanisms of action 13 1.4.1
Collagenolysis 13 1.4.2 Gelatinolysis 15 Acknowledgments 16 References 16 2
Dynamics and Mechanism of Substrate Recognition by Matrix Metalloproteases
23 Ivan E. Collier and Gregory I. Goldberg 2.1 Introduction 23 2.2
Conformational flexibility of MMPs is inexorably linked to collagen
proteolysis 24 2.3 Dynamics of MMP-2 and MMP-9 interaction with gelatin 26
2.4 Surface diffusion: a common mechanism for substrate interaction adapted
by MMP-2 and MMP-9 26 2.5 Dynamics of MMP interaction with collagen fibrils
28 2.6 Mechanism of interaction of MMP-1, MMP-2, MMP-9, and MMP-14 with
collagen substrate involves surface diffusion 28 2.7 Mechanism of MMP-1
diffusion on native collagen fibrils 30 2.8 Triple helical collagen
cleavage - diffusion coupling 31 2.9 Conclusions 34 References 36 3 Matrix
Metalloproteinases: From Structure to Function 41 Marco Fragai and Claudio
Luchinat 3.1 Introduction 41 3.2 Classification and structural features 42
3.3 Catalytic mechanism 45 3.4 Intra- and inter-domain flexibility 47 3.5
Elastin and collagen degradation 47 References 54 4 Metzincin Modulators 61
Dmitry Minond 4.1 Inhibitors 61 4.1.1 Antibodies: targeting beyond the
active site 61 4.1.2 Peptide-based inhibitors 65 4.1.3 Small molecules:
non-zinc binding exosite inhibitors 68 4.1.4 Protein-based inhibitors 78
Summary and future directions 80 References 81 5 Therapeutics Targeting
Matrix Metalloproteinases 85 Jillian Cathcart, Ashleigh Pulkoski-Gross,
Stanley Zucker, and Jian Cao 5.1 Introduction 85 5.2 Peptidomimetic MMP
inhibitors 86 5.3 Structure-based MMPI drug design 87 5.4 Mechanism-based
MMPI design 89 5.5 Allosteric MMPI design 90 5.6 Macromolecular MMP
inhibitors 91 5.7 Chemically-modified tetracyclines 93 5.8 Alternative
approaches 94 5.9 MMPs as anti-targets 95 5.10 Conclusions 97 References 98
6 Matrix Metalloproteinase Modification of Extracellular Matrix-Mediated
Signaling 103 Howard C. Crawford and Sharon M. Stack 6.1 Introduction 103
6.2 The extracellular matrix as a source for signaling ligands 104 6.3 ECM
and mechanosensory signal transduction 106 6.4 Matrix remodeling and
modification of mechano-sensory signaling 108 6.5 Conclusions and future
directions 109 References 109 7 Meprin and ADAM Metalloproteases: Two Sides
of the Same Coin? 115 Christoph Becker-Pauly and Stefan Rose-John 7.1
Introduction 115 7.2 Meprin metalloproteases 116 7.3 Structure of meprin
alpha and meprin ß 116 7.4 Proteomics for the identification of meprin
substrates 118 7.5 Meprins in health and disease 118 7.6 Proteolytic
back-and-forth of meprins and ADAMs 119 7.7 Collagen fibril formation 119
7.8 Angiogenesis and cancer 120 7.9 Inflammation 121 7.10 ADAM Proteases
121 7.11 The ADAM family of proteases 123 7.12 Orchestration of different
pathways by ADAM17 123 7.13 Regulation of ADAM17 activity 123 7.14 Role of
ADAM17 in vivo 125 7.15 Role of ADAM17 in humans 125 References 126 8
Subtracting Matrix Out of the Equation: New Key Roles of Matrix
Metalloproteinases in Innate Immunity and Disease 131 Antoine Dufour and
Christopher M. Overall 8.1 The tale of a frog's tail 131 8.2 The MMP family
132 8.3 Making the cut as immune regulators 133 8.4 Enter the "omics" era:
genomics, proteomics and degradomics 137 8.5 ECM versus non-ECM MMP
substrates 138 8.6 Moonlighting protein substrates: intracellular proteins
cleaved outside the cell 142 8.7 Intracellular protein substrates cleaved
inside the cell by MMPs 143 8.8 Non-proteolytic roles of MMPs: missed in
the myth? 145 8.9 The fairy tail of a frog has an unexpected ending 149
Acknowledgements 149 References 149 9 MMPs: From Genomics to Degradomics
153 Barbara Grünwald, Pascal Schlage, Achim Krüger, and Ulrich auf dem
Keller 9.1 Introduction 153 9.1.1 Genomics: general aspects 154 9.1.2 The
genomics approach to MMP function in cancer 155 9.1.3 Taking first steps
towards MMP inhibition in cancer therapy 156 9.1.4 Lessons from the failure
of unselective MMP inhibition 157 9.1.5 Limitations of the genomic approach
to MMP function 160 9.1.6 Approaching proteolysis as a system 161 9.2
Degradomics - An Overview 164 9.2.1 Global assessment of MMP expression and
activity 166 9.2.2 Defining MMP active site specificity 168 9.2.3 MMP
substrate degradomics 169 9.2.4 Targeted degradomics 171 9.2.5 Data
integration and repositories 173 9.3 Conclusions 174 Acknowledgments 174
References 174 10 MMPs in Biology and Medicine 183 Di Jia, Roopali Roy, and
Marsha A. Moses 10.1 Introduction 183 10.2 Functional roles of MMPs and
ADAMs 184 10.2.1 ECM remodeling 184 10.2.2 Processing of growth factors and
receptors 185 10.2.3 Modulation of cell migration, invasion, proliferation,
and epithelial to mesenchymal transition (EMT) 186 10.2.4 Regulation of
angiogenesis 187 10.3 MMPs as diagnostic and prognostic biomarkers of
cancer 187 10.3.1 Breast cancer 188 10.3.2 Prostate cancer 189 10.3.3 Lung
cancer 190 10.3.4 Pancreatic cancer 191 10.3.5 Ovarian cancer 192 10.4
MMPs/ADAMs as diagnostic and prognostic biomarkers for non-neoplastic
diseases 192 10.4.1 Cardiovascular diseases 193 10.4.2 Endometriosis 193
10.4.3 Preeclampsia 195 10.4.4 Arthritis 196 10.5 MMPs as biomarkers of
therapeutic efficacy 197 10.6 MMP-specific molecular imaging for
noninvasive disease detection 201 10.7 Conclusions 202 Acknowledgments 203
References 203 Index 215
List of Contributors ix 1 Matrix Metalloproteinases: From Structure to
Function 1 Maciej J. Stawikowski and Gregg B. Fields 1.1 Introduction 1 1.2
Structures of MMPs 1 1.2.1 General MMP structure and domain organization 1
1.2.2 Catalytic domain 2 1.2.3 Catalytic mechanism 3 1.2.4 Fibronectin type
II-like inserts 3 1.2.5 Linker region 4 1.2.6 Hemopexin-like domain 6 1.2.7
Transmembrane domain and cytoplasmic tail 7 1.3 Overview of MMP substrate
specificity 8 1.3.1 ECM substrates 9 1.3.2 Cell surface substrates 10 1.3.3
Intracellular MMP targets 11 1.4 Selective mechanisms of action 13 1.4.1
Collagenolysis 13 1.4.2 Gelatinolysis 15 Acknowledgments 16 References 16 2
Dynamics and Mechanism of Substrate Recognition by Matrix Metalloproteases
23 Ivan E. Collier and Gregory I. Goldberg 2.1 Introduction 23 2.2
Conformational flexibility of MMPs is inexorably linked to collagen
proteolysis 24 2.3 Dynamics of MMP-2 and MMP-9 interaction with gelatin 26
2.4 Surface diffusion: a common mechanism for substrate interaction adapted
by MMP-2 and MMP-9 26 2.5 Dynamics of MMP interaction with collagen fibrils
28 2.6 Mechanism of interaction of MMP-1, MMP-2, MMP-9, and MMP-14 with
collagen substrate involves surface diffusion 28 2.7 Mechanism of MMP-1
diffusion on native collagen fibrils 30 2.8 Triple helical collagen
cleavage - diffusion coupling 31 2.9 Conclusions 34 References 36 3 Matrix
Metalloproteinases: From Structure to Function 41 Marco Fragai and Claudio
Luchinat 3.1 Introduction 41 3.2 Classification and structural features 42
3.3 Catalytic mechanism 45 3.4 Intra- and inter-domain flexibility 47 3.5
Elastin and collagen degradation 47 References 54 4 Metzincin Modulators 61
Dmitry Minond 4.1 Inhibitors 61 4.1.1 Antibodies: targeting beyond the
active site 61 4.1.2 Peptide-based inhibitors 65 4.1.3 Small molecules:
non-zinc binding exosite inhibitors 68 4.1.4 Protein-based inhibitors 78
Summary and future directions 80 References 81 5 Therapeutics Targeting
Matrix Metalloproteinases 85 Jillian Cathcart, Ashleigh Pulkoski-Gross,
Stanley Zucker, and Jian Cao 5.1 Introduction 85 5.2 Peptidomimetic MMP
inhibitors 86 5.3 Structure-based MMPI drug design 87 5.4 Mechanism-based
MMPI design 89 5.5 Allosteric MMPI design 90 5.6 Macromolecular MMP
inhibitors 91 5.7 Chemically-modified tetracyclines 93 5.8 Alternative
approaches 94 5.9 MMPs as anti-targets 95 5.10 Conclusions 97 References 98
6 Matrix Metalloproteinase Modification of Extracellular Matrix-Mediated
Signaling 103 Howard C. Crawford and Sharon M. Stack 6.1 Introduction 103
6.2 The extracellular matrix as a source for signaling ligands 104 6.3 ECM
and mechanosensory signal transduction 106 6.4 Matrix remodeling and
modification of mechano-sensory signaling 108 6.5 Conclusions and future
directions 109 References 109 7 Meprin and ADAM Metalloproteases: Two Sides
of the Same Coin? 115 Christoph Becker-Pauly and Stefan Rose-John 7.1
Introduction 115 7.2 Meprin metalloproteases 116 7.3 Structure of meprin
alpha and meprin ß 116 7.4 Proteomics for the identification of meprin
substrates 118 7.5 Meprins in health and disease 118 7.6 Proteolytic
back-and-forth of meprins and ADAMs 119 7.7 Collagen fibril formation 119
7.8 Angiogenesis and cancer 120 7.9 Inflammation 121 7.10 ADAM Proteases
121 7.11 The ADAM family of proteases 123 7.12 Orchestration of different
pathways by ADAM17 123 7.13 Regulation of ADAM17 activity 123 7.14 Role of
ADAM17 in vivo 125 7.15 Role of ADAM17 in humans 125 References 126 8
Subtracting Matrix Out of the Equation: New Key Roles of Matrix
Metalloproteinases in Innate Immunity and Disease 131 Antoine Dufour and
Christopher M. Overall 8.1 The tale of a frog's tail 131 8.2 The MMP family
132 8.3 Making the cut as immune regulators 133 8.4 Enter the "omics" era:
genomics, proteomics and degradomics 137 8.5 ECM versus non-ECM MMP
substrates 138 8.6 Moonlighting protein substrates: intracellular proteins
cleaved outside the cell 142 8.7 Intracellular protein substrates cleaved
inside the cell by MMPs 143 8.8 Non-proteolytic roles of MMPs: missed in
the myth? 145 8.9 The fairy tail of a frog has an unexpected ending 149
Acknowledgements 149 References 149 9 MMPs: From Genomics to Degradomics
153 Barbara Grünwald, Pascal Schlage, Achim Krüger, and Ulrich auf dem
Keller 9.1 Introduction 153 9.1.1 Genomics: general aspects 154 9.1.2 The
genomics approach to MMP function in cancer 155 9.1.3 Taking first steps
towards MMP inhibition in cancer therapy 156 9.1.4 Lessons from the failure
of unselective MMP inhibition 157 9.1.5 Limitations of the genomic approach
to MMP function 160 9.1.6 Approaching proteolysis as a system 161 9.2
Degradomics - An Overview 164 9.2.1 Global assessment of MMP expression and
activity 166 9.2.2 Defining MMP active site specificity 168 9.2.3 MMP
substrate degradomics 169 9.2.4 Targeted degradomics 171 9.2.5 Data
integration and repositories 173 9.3 Conclusions 174 Acknowledgments 174
References 174 10 MMPs in Biology and Medicine 183 Di Jia, Roopali Roy, and
Marsha A. Moses 10.1 Introduction 183 10.2 Functional roles of MMPs and
ADAMs 184 10.2.1 ECM remodeling 184 10.2.2 Processing of growth factors and
receptors 185 10.2.3 Modulation of cell migration, invasion, proliferation,
and epithelial to mesenchymal transition (EMT) 186 10.2.4 Regulation of
angiogenesis 187 10.3 MMPs as diagnostic and prognostic biomarkers of
cancer 187 10.3.1 Breast cancer 188 10.3.2 Prostate cancer 189 10.3.3 Lung
cancer 190 10.3.4 Pancreatic cancer 191 10.3.5 Ovarian cancer 192 10.4
MMPs/ADAMs as diagnostic and prognostic biomarkers for non-neoplastic
diseases 192 10.4.1 Cardiovascular diseases 193 10.4.2 Endometriosis 193
10.4.3 Preeclampsia 195 10.4.4 Arthritis 196 10.5 MMPs as biomarkers of
therapeutic efficacy 197 10.6 MMP-specific molecular imaging for
noninvasive disease detection 201 10.7 Conclusions 202 Acknowledgments 203
References 203 Index 215
Function 1 Maciej J. Stawikowski and Gregg B. Fields 1.1 Introduction 1 1.2
Structures of MMPs 1 1.2.1 General MMP structure and domain organization 1
1.2.2 Catalytic domain 2 1.2.3 Catalytic mechanism 3 1.2.4 Fibronectin type
II-like inserts 3 1.2.5 Linker region 4 1.2.6 Hemopexin-like domain 6 1.2.7
Transmembrane domain and cytoplasmic tail 7 1.3 Overview of MMP substrate
specificity 8 1.3.1 ECM substrates 9 1.3.2 Cell surface substrates 10 1.3.3
Intracellular MMP targets 11 1.4 Selective mechanisms of action 13 1.4.1
Collagenolysis 13 1.4.2 Gelatinolysis 15 Acknowledgments 16 References 16 2
Dynamics and Mechanism of Substrate Recognition by Matrix Metalloproteases
23 Ivan E. Collier and Gregory I. Goldberg 2.1 Introduction 23 2.2
Conformational flexibility of MMPs is inexorably linked to collagen
proteolysis 24 2.3 Dynamics of MMP-2 and MMP-9 interaction with gelatin 26
2.4 Surface diffusion: a common mechanism for substrate interaction adapted
by MMP-2 and MMP-9 26 2.5 Dynamics of MMP interaction with collagen fibrils
28 2.6 Mechanism of interaction of MMP-1, MMP-2, MMP-9, and MMP-14 with
collagen substrate involves surface diffusion 28 2.7 Mechanism of MMP-1
diffusion on native collagen fibrils 30 2.8 Triple helical collagen
cleavage - diffusion coupling 31 2.9 Conclusions 34 References 36 3 Matrix
Metalloproteinases: From Structure to Function 41 Marco Fragai and Claudio
Luchinat 3.1 Introduction 41 3.2 Classification and structural features 42
3.3 Catalytic mechanism 45 3.4 Intra- and inter-domain flexibility 47 3.5
Elastin and collagen degradation 47 References 54 4 Metzincin Modulators 61
Dmitry Minond 4.1 Inhibitors 61 4.1.1 Antibodies: targeting beyond the
active site 61 4.1.2 Peptide-based inhibitors 65 4.1.3 Small molecules:
non-zinc binding exosite inhibitors 68 4.1.4 Protein-based inhibitors 78
Summary and future directions 80 References 81 5 Therapeutics Targeting
Matrix Metalloproteinases 85 Jillian Cathcart, Ashleigh Pulkoski-Gross,
Stanley Zucker, and Jian Cao 5.1 Introduction 85 5.2 Peptidomimetic MMP
inhibitors 86 5.3 Structure-based MMPI drug design 87 5.4 Mechanism-based
MMPI design 89 5.5 Allosteric MMPI design 90 5.6 Macromolecular MMP
inhibitors 91 5.7 Chemically-modified tetracyclines 93 5.8 Alternative
approaches 94 5.9 MMPs as anti-targets 95 5.10 Conclusions 97 References 98
6 Matrix Metalloproteinase Modification of Extracellular Matrix-Mediated
Signaling 103 Howard C. Crawford and Sharon M. Stack 6.1 Introduction 103
6.2 The extracellular matrix as a source for signaling ligands 104 6.3 ECM
and mechanosensory signal transduction 106 6.4 Matrix remodeling and
modification of mechano-sensory signaling 108 6.5 Conclusions and future
directions 109 References 109 7 Meprin and ADAM Metalloproteases: Two Sides
of the Same Coin? 115 Christoph Becker-Pauly and Stefan Rose-John 7.1
Introduction 115 7.2 Meprin metalloproteases 116 7.3 Structure of meprin
alpha and meprin ß 116 7.4 Proteomics for the identification of meprin
substrates 118 7.5 Meprins in health and disease 118 7.6 Proteolytic
back-and-forth of meprins and ADAMs 119 7.7 Collagen fibril formation 119
7.8 Angiogenesis and cancer 120 7.9 Inflammation 121 7.10 ADAM Proteases
121 7.11 The ADAM family of proteases 123 7.12 Orchestration of different
pathways by ADAM17 123 7.13 Regulation of ADAM17 activity 123 7.14 Role of
ADAM17 in vivo 125 7.15 Role of ADAM17 in humans 125 References 126 8
Subtracting Matrix Out of the Equation: New Key Roles of Matrix
Metalloproteinases in Innate Immunity and Disease 131 Antoine Dufour and
Christopher M. Overall 8.1 The tale of a frog's tail 131 8.2 The MMP family
132 8.3 Making the cut as immune regulators 133 8.4 Enter the "omics" era:
genomics, proteomics and degradomics 137 8.5 ECM versus non-ECM MMP
substrates 138 8.6 Moonlighting protein substrates: intracellular proteins
cleaved outside the cell 142 8.7 Intracellular protein substrates cleaved
inside the cell by MMPs 143 8.8 Non-proteolytic roles of MMPs: missed in
the myth? 145 8.9 The fairy tail of a frog has an unexpected ending 149
Acknowledgements 149 References 149 9 MMPs: From Genomics to Degradomics
153 Barbara Grünwald, Pascal Schlage, Achim Krüger, and Ulrich auf dem
Keller 9.1 Introduction 153 9.1.1 Genomics: general aspects 154 9.1.2 The
genomics approach to MMP function in cancer 155 9.1.3 Taking first steps
towards MMP inhibition in cancer therapy 156 9.1.4 Lessons from the failure
of unselective MMP inhibition 157 9.1.5 Limitations of the genomic approach
to MMP function 160 9.1.6 Approaching proteolysis as a system 161 9.2
Degradomics - An Overview 164 9.2.1 Global assessment of MMP expression and
activity 166 9.2.2 Defining MMP active site specificity 168 9.2.3 MMP
substrate degradomics 169 9.2.4 Targeted degradomics 171 9.2.5 Data
integration and repositories 173 9.3 Conclusions 174 Acknowledgments 174
References 174 10 MMPs in Biology and Medicine 183 Di Jia, Roopali Roy, and
Marsha A. Moses 10.1 Introduction 183 10.2 Functional roles of MMPs and
ADAMs 184 10.2.1 ECM remodeling 184 10.2.2 Processing of growth factors and
receptors 185 10.2.3 Modulation of cell migration, invasion, proliferation,
and epithelial to mesenchymal transition (EMT) 186 10.2.4 Regulation of
angiogenesis 187 10.3 MMPs as diagnostic and prognostic biomarkers of
cancer 187 10.3.1 Breast cancer 188 10.3.2 Prostate cancer 189 10.3.3 Lung
cancer 190 10.3.4 Pancreatic cancer 191 10.3.5 Ovarian cancer 192 10.4
MMPs/ADAMs as diagnostic and prognostic biomarkers for non-neoplastic
diseases 192 10.4.1 Cardiovascular diseases 193 10.4.2 Endometriosis 193
10.4.3 Preeclampsia 195 10.4.4 Arthritis 196 10.5 MMPs as biomarkers of
therapeutic efficacy 197 10.6 MMP-specific molecular imaging for
noninvasive disease detection 201 10.7 Conclusions 202 Acknowledgments 203
References 203 Index 215